Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1986; 79(Suppl 12): 55–63.
PMCID: PMC1290129

An overview of the management of cystic fibrosis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Robinson MJ, Norman AP. Life tables for cystic fibrosis. Arch Dis Child. 1975 Dec;50(12):962–965. [PMC free article] [PubMed]
  • Phelan PD, Allan JL, Landau LI, Barnes GL. Improved survival of patients with cystic fibrosis. Med J Aust. 1979 Apr 7;1(7):261–263. [PubMed]
  • Wilmott RW, Tyson SL, Dinwiddie R, Matthew DJ. Survival rates in cystic fibrosis. Arch Dis Child. 1983 Oct;58(10):835–836. [PMC free article] [PubMed]
  • Phelan P, Hey E. Cystic fibrosis mortality in England and Wales and in Victoria, Australia 1976-80. Arch Dis Child. 1984 Jan;59(1):71–73. [PMC free article] [PubMed]
  • Shwachman H, Redmond A, Khaw KT. Studies in cystic fibrosis. Report of 130 patients diagnosed under 3 months of age over a 20-year period. Pediatrics. 1970 Sep;46(3):335–343. [PubMed]
  • Stern RC, Boat TF, Doershuk CF, Tucker AS, Primiano FP, Jr, Matthews LW. Course of cystic fibrosis in 95 patients. J Pediatr. 1976 Sep;89(3):406–411. [PubMed]
  • David TJ, Phillips BM. Overdiagnosis of cystic fibrosis. Lancet. 1982 Nov 27;2(8309):1204–1206. [PubMed]
  • GIBSON LE, COOKE RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959 Mar;23(3):545–549. [PubMed]
  • LOBECK CC, MCSHERRY NR. Response of sweat electrolyte concentrations to 9 alpha--fluorohydrocortisone in patients with cystic fibrosis and their families. J Pediatr. 1963 Mar;62:393–398. [PubMed]
  • Hodson ME, Beldon I, Power R, Duncan FR, Bamber M, Batten JC. Sweat tests to diagnose cystic fibrosis in adults. Br Med J (Clin Res Ed) 1983 Apr 30;286(6375):1381–1383. [PMC free article] [PubMed]
  • Carter EP, Barrett AD, Heeley AF, Kuzemko JA. Improved sweat test method for the diagnosis of cystic fibrosis. Arch Dis Child. 1984 Oct;59(10):919–922. [PMC free article] [PubMed]
  • Green A, Dodds P, Pennock C. A study of sweat sodium and chloride; criteria for the diagnosis of cystic fibrosis. Ann Clin Biochem. 1985 Mar;22(Pt 2):171–174. [PubMed]
  • Shmerling DH, Forrer JC, Prader A. Fecal fat and nitrogen in healthy children and in children with malabsorption or maldigestion. Pediatrics. 1970 Nov;46(5):690–695. [PubMed]
  • Bonin A, Roy CC, Lasalle R, Weber A, Morin CL. Fecal chymotrypsin: a reliable index of exocrine pancreatic function in children. J Pediatr. 1973 Oct;83(4):594–600. [PubMed]
  • Heeley AF, Heeley ME, King DN, Kuzemko JA, Walsh MP. Screening for cystic fibrosis by died blood spot trypsin assay. Arch Dis Child. 1982 Jan;57(1):18–21. [PMC free article] [PubMed]
  • Wilcken B, Brown AR, Urwin R, Brown DA. Cystic fibrosis screening by dried blood spot trypsin assay: results in 75,000 newborn infants. J Pediatr. 1983 Mar;102(3):383–387. [PubMed]
  • Brown RC, Chalmers DM, Rowe VL, Kelleher J, Littlewood JM, Losowsky MS. Comparison of the diagnostic value of serum pancreatic isoamylase and immunoreactive trypsin measurement in patients with cystic fibrosis. J Clin Pathol. 1982 May;35(5):547–549. [PMC free article] [PubMed]
  • Dandona P, Hodson M, Bell J, Ramdial L, Beldon I, Batten JC. Serum immunoreactive trypsin in cystic fibrosis. Thorax. 1981 Jan;36(1):60–62. [PMC free article] [PubMed]
  • Wilson-Sharp RC, Irving HC, Brown RC, Chalmers DM, Littlewood JM. Ultrasonography of the pancreas, liver, and biliary system in cystic fibrosis. Arch Dis Child. 1984 Oct;59(10):923–926. [PMC free article] [PubMed]
  • Hadorn B, Johansen PG, Anderson CM. Pancreozymin secretin test of exocrine pancreatic funtion in cystic fribrosis and the significance of the result for the pathogenesis of the disease. Can Med Assoc J. 1968 Feb 24;98(8):377–385. [PMC free article] [PubMed]
  • Wong LT, Turtle S, Davidson AG. Secretin pancreozymin stimulation test and confirmation of the diagnosis of cystic fibrosis. Gut. 1982 Sep;23(9):744–750. [PMC free article] [PubMed]
  • Aggett PJ, Cavanagh NP, Matthew DJ, Pincott JR, Sutcliffe J, Harries JT. Shwachman's syndrome. A review of 21 cases. Arch Dis Child. 1980 May;55(5):331–347. [PMC free article] [PubMed]
  • Mearns MB. Treatment and prevention of pulmonary complications of cystic fibrosis in infancy and early childhood. Arch Dis Child. 1972 Feb;47(251):5–11. [PMC free article] [PubMed]
  • Jusko WJ, Mosovich LL, Gerbracht LM, Mattar ME, Yaffe SJ. Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis. Pediatrics. 1975 Dec;56(6):1038–1044. [PubMed]
  • Lambert HP. Clinical significance of tissue penetration of antibiotics in the respiratory tract. Scand J Infect Dis Suppl. 1978;(14):262–266. [PubMed]
  • Loening-Baucke VA, Mischler E, Myers MG. A placebo-controlled trial of cephalexin therapy in the ambulatory management of patients with cystic fibrosis. J Pediatr. 1979 Oct;95(4):630–637. [PubMed]
  • Brown J. Efficacy of antimicrobial drugs against staphylococci in cystic fibrosis. Aust Paediatr J. 1980 Sep;16(3):207–209. [PubMed]
  • Hoiby N, Flensborg EW, Beck B, Friis B, Jacobsen SV, Jacobsen L. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand J Respir Dis. 1977 Apr;58(2):65–79. [PubMed]
  • Wientzen R, Prestidge CB, Kramer RI, McCracken GH, Nelson JD. Acute pulmonary exacerbations in cystic fibrosis. A double-blind trial of tobramycin and placebo therapy. Am J Dis Child. 1980 Dec;134(12):1134–1138. [PubMed]
  • Beaudry PH, Marks MI, McDougall D, Desmond K, Rangel R. Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis? J Pediatr. 1980 Jul;97(1):144–147. [PubMed]
  • Hyatt AC, Chipps BE, Kumor KM, Mellits ED, Lietman PS, Rosenstein BJ. A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis. J Pediatr. 1981 Aug;99(2):307–314. [PubMed]
  • Conway SP, Miller MG, Ramsden C, Littlewood JM. Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin. Acta Paediatr Scand. 1985 Jan;74(1):107–113. [PubMed]
  • Szaff M, Høiby N, Flensborg EW. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand. 1983 Sep;72(5):651–657. [PubMed]
  • Hodson ME, Penketh AR, Batten JC. Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet. 1981 Nov 21;2(8256):1137–1139. [PubMed]
  • Kun P, Landau LI, Phelan PD. Nebulized gentamicin in children and adolescents with cystic fibrosis. Aust Paediatr J. 1984 Mar;20(1):43–45. [PubMed]
  • Miller MG, Ghoneim AT, Littlewood JM. Use of enoxacin in a patient with cystic fibrosis. Lancet. 1985 Mar 16;1(8429):646–646. [PubMed]
  • Yeh TF, Luken JA, Thalji A, Raval D, Carr I, Pildes RS. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus--a double-blind controlled study. J Pediatr. 1981 Jan;98(1):137–145. [PubMed]
  • Holzer FJ, Olinsky A, Phelan PD. Variability of airways hyper-reactivity and allergy in cystic fibrosis. Arch Dis Child. 1981 Jun;56(6):455–459. [PMC free article] [PubMed]
  • Auerbach HS, Williams M, Kirkpatrick JA, Colten HR. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet. 1985 Sep 28;2(8457):686–688. [PubMed]
  • Gow R, Bradbear R, Francis P, Shepherd R. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine. Lancet. 1981 Nov 14;2(8255):1071–1074. [PubMed]
  • Chalmers DM, Brown RC, Miller MG, Clarke PC, Kelleher J, Littlewood JM, Losowsky MS. The influence of long-term cimetidine as an adjuvant to pancreatic enzyme therapy in cystic fibrosis. Acta Paediatr Scand. 1985 Jan;74(1):114–117. [PubMed]
  • Congden PJ, Bruce G, Rothburn MM, Clarke PC, Littlewood JM, Kelleher J, Losowsky MS. Vitamin status in treated patients with cystic fibrosis. Arch Dis Child. 1981 Sep;56(9):708–714. [PMC free article] [PubMed]
  • Elias E, Muller DP, Scott J. Association of spinocerebellar disorders with cystic fibrosis or chronic childhood cholestasis and very low serum vitamin E. Lancet. 1981 Dec 12;2(8259):1319–1321. [PubMed]
  • Stead RJ, Redington AN, Hinks LJ, Clayton BE, Hodson ME, Batten JC. Selenium deficiency and possible increased risk of carcinoma in adults with cystic fibrosis. Lancet. 1985 Oct 19;2(8460):862–863. [PubMed]
  • Henderson MJ, Littlewood JM, Miller M. Interpretation of sweat sodium and chloride concentrations. Ann Clin Biochem. 1986 Jan;23(Pt 1):109–109. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press